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Summary
Peptide deformylase (PDF) catalyses the removal of
the formyl group from the ﬁrst methionine of nascent
proteins. Type 1 PDFs are found in bacteria and have
orthologues in most eukaryotes. Type 2 PDFs are
restricted to bacteria. Type 3 enzymes are found in
Archaea and trypanosomatids and have not been
studied experimentally yet. Thus, TbPDF1 and
TbPDF2, the two PDF orthologues of the parasitic
protozoa Trypanosoma brucei, are of type 3. An
experimental analysis of these enzymes shows that
both are mitochondrially localized, but that only
TbPDF1 is essential for normal growth. Recombinant
TbPDF1 exhibits PDF activity with a substrate speci-
ﬁcity identical to that of bacterial enzymes. Consis-
tent with these results, TbPDF1 is required for
oxidative but not for mitochondrial substrate-level
phosphorylation. Ablation of TbPDF2, in contrast,
does neither affect growth on standard medium nor
oxidative phosphorylation. However, a reduced level
of TbPDF2 slows down growth in a medium that
selects for highly efficient oxidative phosphorylation.
Furthermore, combined ablation of TbPDF1 and
TbPDF2 results in an earlier growth arrest than is
observed by downregulation of TbPDF1 alone. These
results suggest that TbPDF2 is functionally linked to
TbPDF1, and that it can inﬂuence the efficiency of
oxidative phosphorylation.
Introduction
Bacterial and organellar initiator tRNAsMet are only func-
tional when the methionine they carry is formylated. Addi-
tion of the formyl group to the charged initiator tRNAMet is
catalysed by the methionyl-tRNAMet formyltransferase
(MTF). During translation initiation, the formylated initiator
tRNAMet interacts with the bacterial-type initiation factor 2,
and the resulting complex binds to the ribosome in a
GTP-dependent way (Mayer et al., 2001). Thus, newly
synthesized proteins emerging from ribosomes of bacte-
ria and organelles carry formyl-methionines at their
N-termini. In many cases, this formyl-methionine needs to
be removed for the protein to be functional (Giglione and
Meinnel, 2001a; Giglione et al., 2004). However, ami-
nopeptidases, which cleave off N-terminal methionines,
can only process methionines that are not formylated.
Therefore, a peptide deformylase (PDF) is needed which
removes the formyl group (Giglione and Meinnel, 2001a;
Giglione et al., 2004).
For many years it was thought that PDFs are speciﬁc for
bacteria, and they were therefore considered to be excel-
lent targets for antibacterial drugs. Indeed, several PDF
inhibitors are being tested in clinical trials (Boularot et al.,
2004; Leeds and Dean, 2006). However, more recent
studies have shown that PDF homologues are also
encoded in essentially all eukaryotic and in some archaeal
genomes.The feweukaryotic PDFs that have been studied
in more detail are essential proteins (Giglione et al., 2003;
Lee et al., 2004) that are targeted to chloroplasts and to
mitochondria (Lee et al., 2004; Nguyen et al., 2003; Serero
et al., 2003).
Trypanosoma brucei is a parasitic protozoa that occurs
in sub-Saharan Africa. It has a complex life cycle and is
transmitted between mammalian hosts through a tsetse
ﬂy vector. T. brucei causes human sleeping sickness and
various diseases in other animals. If left untreated, sleep-
ing sickness is invariable fatal. However, treatment of the
disease is still in a very unsatisfactory state, and the only
effective drug against the late stage of the disease, which
is in use for more than 50 years, causes death in 3–10%
of the patients (Lüscher et al., 2007). T. brucei is related
to Trypanosoma cruzi, the causative agent of Chagas
disease in Latin America, as well as Leishmania spp. that
occur in much of the tropical and subtropical world and
that cause the different forms of leishmaniasis.
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As in other eukaryotes, mitochondrial translation in the
parasitic protozoa T. brucei is of the bacterial-type
(Schneider, 2001). Consistent with this, it was shown that
mitochondrial translation initiation in T. brucei requires a
formylated tRNAMet (Tan et al., 2002). However, due to the
complete lack of mitochondrial tRNA genes (Schneider
and Marechal-Drouard, 2000; Bhattacharyya and Adhya,
2004), it is not a bacterial-type initiator tRNAMet that
becomes formylated, but the elongator tRNAMet that is
imported from the cytosol. The formylation is catalysed by
an MTF that, unlike its counterparts in other organisms,
recognizes the imported elongator tRNAMet. Thus, we ﬁnd
the surprising situation in T. brucei mitochondria that the
elongator tRNAMet is functional in translation initiation pro-
vided that it is formylated (Martin, 2002). This highlights
how crucial tRNA formylation is in mitochondria. In agree-
ment with these ﬁndings, it was shown that the main
determinant recognized by the mitochondrial initiation
factor 2 of T. brucei is the formylated methionine (Char-
rière et al., 2005). It is therefore clear that newly synthe-
sized mitochondrially encoded proteins of T. brucei carry
an N-terminal formyl-methionine.
Mitochondrial translation in T. brucei has proven to be
difficult to study. Thus, except for two mitochondrially syn-
thesized proteins that are probably not processed, it is not
known whether the formyl group is removed (Horvath
et al., 2000a, b). Here we show that the T. brucei genome
encodes two distinct putative PDF orthologues. One of
the proteins was recombinantly expressed and exhibited
deformylase activity. Furthermore, as predicted for
deformylases, both T. brucei PDF orthologues are local-
ized in mitochondria and required for efficient oxida-
tive phosphorylation (OXPHOS), a process that in part
depends on mitochondrially encoded proteins.
Results
Two PDF orthologues in T. brucei
The T. brucei genome encodes open reading frames
(ORFs) for two putative PDF orthologues. The proteins
have a predicted molecular weight of 30 kDa (TbPDF1:
accession numbers Tb11.01.6120 and AF177768] and
42 kDa (TbPDF2: accession number Tb09.211.0190]
respectively. They contain the three signature sequences
that deﬁne the PDF protein family (Giglione and Meinnel,
2001b; Meinnel, 2000), even though motif 1 lacks the
conserved glutamine residue that appears to be crucial for
the recognition of the formyl group by TbPDF1 (Meinnel
et al., 1997) (Fig. 1). The two T. brucei PDFs share only a
limited identity of 30% that is restricted to the C-terminal
half of TbPDF1. However, both proteins have conserved
orthologues in Leishmania major and T. cruzi with which
they share an overall identity of 63% (for TbPDF1) and
75% (for TbPDF2). Interestingly, unlike the TbPDF2, the
ﬁrst PDF signature sequence of the L. major and the
T. cruzi TbPDF2 orthologues includes the conserved
glutamine residue of motif 1 (Fig. 1). The closest non-
trypanosomatidal orthologues that are identiﬁed by BLAST
analysis are the PDF1B of Arabidopsis thaliana (for
TbPDF1) and the PDF of the bacteria Leptospira interro-
gans (for TbPDF2). Finally, compared with bacterial
PDFs, trypanosomatidal PDF orthologues have both an
N- and a C-terminal extension.
Biochemical analysis of recombinant TbPDF1
Based on changes in the conserved motifs, it has been
suggested in a recent phylogenetic analysis that trypano-
somal and archaeal PDFs form a separate group, termed
type 3 PDFs (Giglione et al., 2004). Thus, in order to test
whether the trypanosomal PDF orthologues have PDF
activity, we prepared recombinant TbPDF1, the more con-
served of the two trypanosomal PDFs. To do so, full-
length TbPDF1 and three variants thereof lacking either
the ﬁrst 30 amino acids (TbPDF1/31–260), the last 51
amino acids (TbPDF1/1–209) or both (TbPDF1/31–209)
were expressed in Escherichia coli (Fig. 2A). All proteins
carried a hexahistidine tag at their C-termini. Analysis of
crude extracts with anti-hexahistidine tag antibodies
showed that, whereas TbPDF1/31–260 was expressed at
high levels, only low amounts of the other TbPDF1 vari-
ants accumulated (not shown). Thus, the presence of the
N-terminal 30 amino acids and the absence of the
C-terminal 51 amino acids had a deleterious effect on
TbPDF1 expression.
Using nickel column affinity chromatography, the highly
expressed TbPDF1/31–260 variant was puriﬁed to homo-
geneity as illustrated by the Coomassie-stained gel in
Fig. 2B. By the same method, we obtained highly
enriched fraction for full-length TbPDF1 and the TbPDF1/
31–209 variant. Expression of the TbPDF1/1–209 variant
was very weak. The corresponding nickel column eluate
was poorly enriched in recombinant protein as a result,
and contained a major contaminant that co-migrates with
the recombinant protein as evidenced by immunoblot
analysis using anti-Tag antibodies (Fig. 2B, lane TbPDF1/
1–209).
Previous work had indicated that the catalytic core of
bacterial PDFs is highly resistant to trypsin digestion
(Meinnel et al., 1996). Thus, we expect TbPDF1 to
behave the same way. The predicted catalytic core of
TbPDF1, encompassing approximately residues 36–198,
is present in all four recombinant TbPDF1 variants. Con-
sistent with this, low concentrations of trypsin were suffi-
cient to convert full-length TbPDF1 into a trypsin-resistant
fragment of approximately 28 kDa (Fig. 2C, top panel).
The fragment still reacted with the anti-His-tag antibodies,
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indicating that its C-terminus was intact. TbPDF1/31–260
co-migrated with the proteolytic fragment of the full-length
enzyme and resisted proteolytic attack within the same
range of concentration (Fig. 2C, middle panel). In con-
trast, TbPDF1/31–209 (Fig. 2C, bottom panel) and
TbPDF1/1–209 (not shown) were completely hydrolysed
at very low concentrations of trypsin. These experiments
show that TbPDF1 has a protease-resistant core similar in
size to the one found in bacterial PDFs. Furthermore, the
removal of the N-terminus at very low trypsin concentra-
tions suggests that, in agreement with previous analyses
of PDFs from other organisms, this extension has no
deﬁned secondary structure.
Finally, full-length recombinant TbPDF1 and the most
stable truncated variant TbPDF1/31–260 were assayed
for deformylation activity. Both proteins were able to
remove the formyl group from formylated peptides con-
sisting of two or more amino acids in length (Table 1).
Highest activities were observed for dipeptides containing
either formylated methionine or phenylalanine. Interest-
ingly, however, a dipeptide containing isoleucine, even
though it is also hydrophobic in nature, was a much worse
substrate (Table 1). Thus, the substrate speciﬁcity of
TbPDF1 is identical to that of bacterial PDFs, which also
discriminate between phenylalanine and isoleucine
(Ragusa et al., 1999).
The observed speciﬁc activity of TbPDF1 was very low
(kcat/KM = 8 M-1 s-1) but similar to the one observed for
human (Serero et al., 2001; Serero et al., 2003; Lee et al.,
2004) and Plasmodium falciparum PDFs (Bracchi-Ricard
et al., 2001) when tested with comparable substrates.
Speciﬁc activities of the same order of magnitude have
also been described for some bacterial PDFs. In these
cases, the low activities could be explained by an
exchange of the metal cation found in the active site in
vivo for another less efficient one that may render the
Fig. 1. Trypanosoma brucei contains two
PDF orthologues. Multiple sequence
alignment of the TbPDF1 and TbPDF2 and
their corresponding orthologues in Leishmania
major (LmPDF1, LmPDF2) and in
Trypanosoma cruzi (TcPDF1, TcPDF2). The
sequences were aligned using the CLUSTAL W
program with default parameters. Strictly
conserved residues and conservative
replacements are shown in black and grey
boxes respectively. The three PDF signature
sequences (Giglione and Meinnel, 2001b) are
indicated in the three large boxes.
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enzyme unstable (Ragusa et al., 1998). Thus, this may
also apply to TbPDF1, as measurements of the metal
content show that zinc is present (0.6  0.2 mole mole-1
PDF) in all four variants of the protein. In analogy with
results in E. coli (Meinnel and Blanquet, 1995), this indi-
cates that zinc may have replaced another more efficient
cation that is used in vivo (Ragusa et al., 1998). Unfortu-
nately, as previously reported for human PDF (Lee et al.,
2004), all attempts to optimize the activity by using
oxidant scavengers, or by replacing zinc by other cations,
were unsuccessful. Furthermore, we cannot exclude that
imidazole elution from the nickel column could participate
in enzyme inactivation via metal cation removal.
Finally, as the normally conserved glutamine in motif 1
of TbPDF1 is substituted by a lysine (Fig. 1), we have also
expressed and puriﬁed a TbPDF1 variant where the con-
served glutamine was reintroduced. However, the result-
ing TbPDF1 variant was not more active in deformylation
than the wild-type one.
In summary, these results show that TbPDF1, similar to
the PDF of humans and P. falciparum, has deformylase
activity. Furthermore, as for other eukaryotic PDFs, the
activity is not dependent on the presence or absence of
the ﬁrst 30 N-terminal residues.
Intracellular localization of TbPDF1 and TbPDF2
Both trypanosomal PDF orthologues are predicted to
have mitochondrial targeting signals. However, in
T. brucei such predictions are difficult, as mitochondrial
presequences can be very short (Häusler et al., 1997).
Thus, in order to determine the localization of the two
proteins, we prepared transgenic procyclic T. brucei cell
lines, allowing inducible expression of TbPDF1 and
TbPDF2 versions that carry the Ty1-peptide as a
C-terminal epitope tag (Bastin et al., 1996). Immunoblot
Fig. 2. Biochemical analysis of recombinant TbPDF1.
A. Schematic representation of the 6xHis-tagged TbPDF1 variants that were recombinantly expressed in E. coli.
B. Upper panel, Coomassie-stained 12% SDS polyacrylamide gel containing approximately 2 mg each of Ni-NTA agarose-puriﬁed pool
containing the recombinant proteins. In the case of TbPDF/1–209, purity was assessed to be less than 10% because of poor overexpression
and co-elution with many contaminating proteins, including a major one co-eluting with most variants. The molecular weight markers in the
second lane correspond to 43, 30, 20.1 and 14.4 kDa. Lower panel, immunoblot analysis using anti-His-tag antibodies of a duplicate gel
containing the same samples as in the upper panel.
C. Proteolytic digestion of the recombinant TbPDF1 variants with the indicated concentrations of trypsin (ng ml-1). Proteins were detected by
immunoblot analysis using anti-His-tag antibodies. The asterisk shows the trypsin-resistant core of full-length TbPDF1 that in size corresponds
to trypsin-resistant TbPDF1/31–260 seen in the middle panel.
Table 1. Substrate speciﬁcity of recombinant TbPDF1.
Peptidea Relative deformylation rateb
Fo-Met-X 100
Fo-Phe-X 40
Fo-Ala-X 2
Fo-Ile-X 3
Fo-Met < < 1
a. X indicates that the peptide is composed of an equimolar mixture
of 19 usual amino acids.
b. Deformylation rates were measured using the TbPDF1/31–260. A
value of 100 was given to the highest value. It corresponds to a
deformylation rate of 13.5 pmole of hydrolysed peptide per minute
and per mg protein added (0.008 s-1). Standard deviation was < 20%.
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analysis using anti-Ty1 antibody showed that, in both
induced cell lines, a single band was detected that corre-
sponded to the expected molecular weights of TbPDF1
and TbPDF2 respectively (Fig. 3A). Immunoﬂuorescence
of either of the two cell lines revealed a reticulate staining
pattern, speciﬁc for induced cells, that is identical to the
one seen for the mitochondrial marker (Fig. 3B). Thus,
these results show that both TbPDF1 and TbPDF2 are
localized in mitochondria.
Effect of RNAi-mediated ablation of TbPDF1 and
TbPDF2 on growth
In order to study the importance of TbPDF1 and TbPDF2
for growth and survival of procyclic T. brucei, we estab-
lished transgenic cell lines that allow individual or com-
bined RNAi-mediated ablation of the two enzymes.
Growth of the RNAi cell lines was tested (i) in the standard
medium SDM-79 (Brun and Schönenberger, 1979), which
contains proline and glucose as the major energy sources
(Fig. 4A and B), as well as (ii) in SDM-80 (Lamour et al.,
2005), a modiﬁed version of SDM-79 that lacks glucose
(Fig. 4C).
Fig. 3. Intracellular localization of TbPDF1 and TbPDF2.
Localization of trypanosomal PDF orthologues.
A. Immunoblot analysis of total cellular extracts of two transgenic
T. brucei cell lines expressing TbPDF1 and TbPDF2 carrying
Ty1-tags at their C-termini. Expression is under the control of the
tetracycline inducible (–, +Tet) procyclin promoter. The Ty1-tag was
detected using the monoclonal BB2 antibody.
B. Immunoﬂuoresence analysis of the same cell lines shown in A.
The top two lines of each panels show the Nomarski picture and
the DNA-staining using DAPI. The lower two lines of the panels
depict the staining seen by using a polyclonal antibody against a
subunit of the ATPase, which serves as a mitochondrial marker,
and the staining obtained by using the Ty1-tag-speciﬁc monoclonal
BB2 antibody.
Fig. 4. Effect of RNAi-mediated ablation of TbPDF1 and TbPDF2
on growth.
A. Growth curves in standard culture medium SDM-79 of
uninduced and induced (–, +Tet) clonal TbPDF1 (left panel) and
TbPDF2 (right panel) RNAi cell lines. The panels below the graphs
show Northern blots for the corresponding TbPDF mRNAs. The
rRNAs in the lower panel serve as loading controls. Time of
sampling is indicated by the arrows.
B. Growth curve in standard culture medium SDM-79 of an unin-
duced and induced (–, +Tet) culture of a representative clonal
TbPDF1/TbPDF2 double-RNAi cell line. The panel below the graph
shows a Northern blot for the two TbPDF mRNAs.
C. Growth curves of uninduced and induced TbPDF1 and TbPDF2
RNAi cell lines in culture medium SDM-80 that lacks glucose (– Glu).
All growth curves have been determined at least three times in inde-
pendent experiments and were shown to be highly reproducible.
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Ablation of TbPDF1 caused a growth arrest in SDM-79
after approximately 150 h of induction (Fig. 4A, left
graph). However, when cells ablated for TbPDF2 were
tested in the same medium, growth was not affected.
Thus, TbPDF2, in contrast to TbPDF1, appears to be
dispensable for growth on SDM-79. However, a double-
RNAi cell line allowing simultaneous ablation of TbPDF1
and TbPDF2 (Fig. 4B) shows a growth arrest after
approximately 70 h of induction, much earlier than the
150 h that is needed if only TbPDF1 is ablated. These
results indicate that, whereas a reduced level of TbPDF2
alone does not affect growth in SDM-79, it causes the
growth arrest induced by ablation of TbPDF1 to occur
much earlier.
When tested in glucose-free SDM-80 medium, the
growth arrest caused by ablation of TbPDF1 occurs
already approximately 90 h after induction (Fig. 4C, left
panel). Furthermore, in SDM-80, unlike in SDM-79, a slow
growth phenotype is also detected for the induced
TbPDF2 RNAi cell line (Fig. 4C, right panel).
In procyclic T. brucei, glucose, after conversion into
pyruvate, is mainly used for mitochondrial substrate-level
phosphorylation (SUBPHOS) in the trypanosome-speciﬁc
acetate:succinate CoA transferase/succinyl-CoA syn-
thetase (ASCT) cycle (Van Hellemond et al., 1998) and,
not as might be expected, fed into the citric acid cycle
(Bochud-Allemann and Schneider, 2002; van Weelden
et al., 2003). When grown in SDM-79, where glucose is
available, the energy needs of T. brucei can be fulﬁlled
mainly by SUBPHOS. In the glucose-free SDM-80
medium, however, the sole energy source is proline that
can only be utilized by OXPHOS. Growth in SDM-80
therefore selects for cells capable of performing efficient
OXPHOS (Lamour et al., 2005). Thus, the fact that abla-
tion of either of the two proteins causes a stronger growth
phenotype in glucose-free than in the standard medium
suggests that TbPDF1 and to a more limited extent also
TbPDF2 are, at least indirectly, required for efficient
OXPHOS.
Effect of RNAi-mediated ablation of TbPDF1 and
TbPDF2 on mitochondrial ATP production
The proteins encoded in the mitochondrion of T. brucei –
the substrates of TbPDF1 and possibly TbPDF2 – either
function for the most part directly in OXPHOS, or are
components of the mitochondrial translation machinery
that produces them (Feagin, 2000). Thus, should removal
of the formyl group be essential for the function of any of
these mitochondrially encoded proteins, the lack of PDF
activity should ultimately affect OXPHOS. The mitochon-
drion of procyclic T. brucei produces ATP, by OXPHOS as
well as by SUBPHOS linked to the citric acid cycle or the
ASCT cycle (Besteiro et al., 2005). Using isolated mito-
chondria, we have recently established an assay that
allows quantiﬁcation of both modes of ATP production
(Bochud-Allemann and Schneider, 2002; Schneider et al.,
2007). In these assays, OXPHOS is induced by the
addition of either succinate or glycerol-3 phosphate.
As expected, this type of ATP production is antimycin
sensitive. Mitochondrial SUBPHOS, which is resistant to
antimycin, is induced by the addition of a-ketoglutarate
(for the SUBPHOS in the citric acid cycle) or pyruvate (for
the SUBPHOS in the ASCT cycle). In the latter case,
succinate has to be added as a co-substrate. Thus,
25–50% of the ATP produced by the combination of pyru-
vate and succinate is due to OXPHOS and therefore
antimycin sensitive (Bochud-Allemann and Schneider,
2002). Isolated mitochondria of T. brucei are depleted for
nucleotides; therefore, ADP has to be added in all assays.
Atractyloside treatment prevents mitochondrial import of
the added ADP and serves as a control for all modes of
mitochondrial ATP production. Figure 5A shows that, in
line with the deformylase activity of the recombinant
protein, ablation of TbPDF1 results in a loss of OXPHOS
induced either by glycerol-3 phosphate or by succinate,
but does not affect mitochondrial SUBPHOS assayed by
pyruvate or a-ketoglutarate respectively. Ablation of
TbPDF2, on the other hand, does not inﬂuence either
mode of ATP production (Fig. 5B). Thus, TbPDF1, but not
TbPDF2, is required for OXPHOS in isolated organelles.
These results are in agreement with the observation that
TbPDF1 is required for growth in any medium, and
explain why the growth arrest during TbPDF1 RNAi
appears earlier in glucose-free than in the standard
medium (Fig. 4). Isolated mitochondria ablated for
TbPDF2 are not impaired in OXPHOS, which is consistent
with the normal growth of the induced RNAi cell line that
is observed in standard medium. However, ablation of
TbPDF2 reinforces the growth arrest of cells that are
already ablated for TbPDF1 and leads to a slow growth
phenotype in glucose-free medium (Fig. 4). This suggests
that while TbPDF2 is not required for the level of
OXPHOS that is needed under normal growth conditions,
it is nevertheless required for the highly efficient OXPHOS
that is demanded in glucose-free medium.
Discussion
A phylogenetic analysis based on alignments of the three
conserved motifs suggests that the trypanosomal PDFs
are most closely related to the PDFs of Archaea (Giglione
and Meinnel, 2001b). In fact, archaeal and trypanosoma-
tidal PDFs are sufficiently different from all other PDFs to
classify them in an own group, termed type 3 PDFs (Gigli-
one et al., 2004). Archaea do not use formyl-methionine to
initiate protein synthesis; thus, it is not known which reac-
tion archaeal PDF orthologues catalyse. Interestingly,
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however, recombinant PDF1 of T. brucei, a type 3
enzyme, exhibits deformylase activity whose speciﬁcity
mirrors that of bacterial enzymes. The speciﬁc activity of
the recombinant protein is low but comparable to that of
human and P. falciparum PDFs that belong to class 1 A
and 1B respectively (Giglione et al., 2004). Other fea-
tures that are shared between TbPDF1 and the well-
characterized bacterial PDFs are a trypsin-resistant active
core of similar size and the capability to bind metals. In
fact, it is likely that an exchange of a metal ion, of yet
unknown nature, for zinc in the recombinant enzyme is
responsible for the low speciﬁc activity that is observed.
We have previously established that active MTF is
present in the mitochondrion of T. brucei (Tan et al., 2002).
Unexpectedly, due to the absence of mitochondrial tRNA
genes inT. brucei, the tRNAthat becomes formylated is the
elongator tRNAMet imported from the cytosol. The proteins
encoded on the T. brucei mitochondrial DNA are subunits
I–III of cytochrome oxidase, cytochrome b, subunit 6 of the
ATPase, the ribosomal protein Rps12, and at least seven
subunits of the NADH dehydrogenase (Feagin, 2000).
When translated, the corresponding nascent proteins will
necessarily carry a formyl-methionine at their N-termini,
because of mitochondrial MTF activity. Thus, the only
compartment in T. brucei where substrates for PDFs are
present is the mitochondrion. In agreement with this,
TbPDF1 is localized to mitochondria. However, up to now
the N-termini of only two mitochondrially synthesized pro-
teins, cytochrome b and cytochrome oxidase subunit I
(Horvath et al., 2000a, b), have directly been sequenced.
Both of these proteins had to be treated with HCl prior to
sequencing because their N-termini were blocked, sug-
gesting that they consisted of an unprocessed formyl-
methionine. Thus, in vivo evidence for deformylation of
mitochondrially encoded proteins is still lacking, as is also
the case for human mitochondrial proteins (Serero et al.,
2003).
Isolated mitochondria from TbPDF1-ablated cells show
a speciﬁc loss of OXPHOS, but not of SUBPHOS. In
agreement with this, the growth arrest induced by ablation
of TbPDF1 occurs much earlier in glucose-free medium,
that selects for efficient OXPHOS, than in the standard
medium that provides substrates for OXPHOS and mito-
chondrial SUBPHOS. The substrates of PDFs are mito-
chondrially encoded proteins, many of which are required
for OXPHOS but not for mitochondrial SUBPHOS. These
results therefore support the idea that TbPDF1 is a
deformylase.
Unexpectedly, unlike humans (Nguyen et al., 2003;
Serero et al., 2003; Lee et al., 2004) but similar to plants
(Giglione et al., 2000), T. brucei has two PDF homo-
logues, both of which are localized in mitochondria. In
contrast to TbPDF1, TbPDF2 is dispensable for growth on
standard medium. Interestingly, however, TbPDF2-
Fig. 5. Effect of RNAi-mediated ablation of TbPDF1 and TbPDF2
on mitochondrial ATP production. OXPHOS, induced by succinate
or glycerol-3 phosphate, and SUBPHOS, induced by
a-ketoglutarate or pyruvate, were assayed in crude mitochondrial
fractions of TbPDF1 (A) and TbPDF2 (B) RNAi cell lines
respectively. Uninduced cells (– Tet) are shown on the left, induced
cells (+ Tet) on the right of each panel. The substrate tested is
indicated at the top and additions of antimycine (antim.) and
atractyloside (atract.) at the bottom of each panel. ATP productions
in mitochondria isolated from uninduced cells tested without
antimycine or atractyloside are set to 100%. The bars represent
means expressed as percentages from three or more independent
inductions. Standard errors are indicated.
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ablated cells show a slow growth phenotype on glucose-
free medium, suggesting that the function of TbPDF2 is
also, at least indirectly, linked to OXPHOS. Furthermore,
the synergistic growth phenotype observed in the cell line
ablated for both trypanosomal PDFs suggests that the two
proteins are functionally connected.
Given the strong homology of the catalytic domain of
TbPDF2 with other well-characterized PDFs (Giglione and
Meinnel, 2001b), it appears likely that it also has deformy-
lase activity. Thus, TbPDF1 and TbPDF2 may in part have
overlapping functions: TbPDF1 may deformylate all mito-
chondrially synthesized proteins, although some only inef-
ﬁciently, whereas TbPDF2 might be more selective and
only deformylate proteins that are poorly recognized
by TbPDF1. However, attempts to purify recombinant
TbPDF2 have so far been unsuccessful. Furthermore,
overexpression of TbPDF2 did not rescue the growth
arrest that is observed in the induced TbPDF1 RNAi cell
line. The described scenario is therefore mainly based
on speculation, and the function of TbPDF2 remains
unknown at present.
Why are there two PDF orthologues in T. brucei? Inter-
estingly, plants also have two of these enzymes (Giglione
et al., 2000). One is essentially localized in mitochondria
(PDF1A), whereas the other (PDF1B) is found in both
plastids and mitochondria. Unlike PDF1A, PDF1B is
essential for chloroplast function (Giglione and Meinnel,
2001a). Nevertheless, the two proteins are in part func-
tionally redundant. Hence, overexpression of PDF1A
partially compensates for the absence of PDF1B
in chloroplasts, and overexpression of PDF1A can fully
complement the lack of PDF1B (Giglione et al., 2003).
Plant PDFs are believed to mainly differ by their capacity
to bind distinct metal cation, Zn2+ for PDF1A and Fe2+ for
PDF1B (Serero et al., 2001). Consequently, a unique
feature of PDF1B is its strong sensitivity to oxidation. This
led to the proposal that PDF1A was suited for environ-
ments prone to oxidative stress such as mitochondria
(Serero et al., 2001). Trypanosomatids are closely related
to the euglenids, most of which have a plastid. Further-
more, a number of plant-like genes encoding homologues
of proteins found in chloroplasts have been found in the
genome of T. brucei (Hannaert et al. 2003). Thus, it has
been suggested that T. brucei may once have had a
plastid which it has lost secondarily (Martin and Borst,
2003). It is therefore likely that one of the two trypanoso-
mal PDFs represents an evolutionary remnant of a PDF
that originally was also targeted to the plastid. However,
even if the evolutionary history of one of the trypanosomal
PDFs is linked to plastids, it is clear that today both
proteins have a mitochondrial function. TbPDF1 is strictly
required for OXPHOS under all conditions. The require-
ment of TbPDF2 is less stringent but is seen when growth
is tested in glucose-free medium or at limiting concentra-
tions of TbPDF1. Finally, like in plants, it is not unlikely that
the nature of the metal cation bound in vivo could be
different between the two trypanosomal PDFs, each being
more adapted to unique environmental stress conditions.
Recently, a PDF orthologue has been identiﬁed and
characterized in P. falciparum (Meinnel, 2000; Bracchi-
Ricard et al., 2001). PDF inhibitors were shown to interfere
with growth of the intraerythrocytic stage of the parasite
(Bracchi-Ricard et al., 2001; Wiesner et al., 2001). Based
on these observations, it has been proposed that the
plasmodial PDF could be exploited as a novel target for
antimalarial drugs (Meinnel, 2000; Giglione and Meinnel,
2001b). The PDF orthologues of T. brucei are essential for
mitochondrial function, and their sequence is quite diver-
gent from other eukaryotic PDFs. This suggests that also
the trypanosomal PDFs may be suitable drug targets.
Thus, it is possible that the trypanosomal PDFs are
required for processing of subunit 6 of the ATPase, a
mitochondrially encoded protein that was demonstrated to
be essential for both life-cycle stages (Schnaufer et al.,
2005). Unlike T. brucei, for which OXPHOS is speciﬁc for
the insect stage and does not occur in the bloodstream
form of the parasite (Durieux et al., 1991; Schneider,
2001), Leishmania and T. cruzi need a functional respira-
tory chain for survival in their respective vertebrate hosts
(Van Hellemond and Tielens, 1997). Thus, in T. cruzi and
Leishmania, PDF orthologues appear to be excellent drug
targets to ﬁght the associated diseases.
Experimental procedures
Puriﬁcation of recombinant TbPDF1 from E. coli
The ORFs corresponding to full-length TbPDF1 (Fig. 1) and
the described variants thereof (Fig. 2) were cloned into
pQE60 (Qiagen), a vector specialized for in-frame fusions
with a C-terminal 6xHis tag. Transfected E. coli M15 was
grown at 30°C in 2xTY containing 50 mg ml-1 ampicillin and
25 mg ml-1 kanamycin. Expression of the recombinant pro-
teins was induced with 0.1 mM IPTG at an OD650 of 0.9 for
4 h. Cells were harvested and resuspended in 20 mM Tris-
HCl pH 8.0, 20 mM 2-mercaptoethanol, 0.3 M NaCl (buffer A)
containing 10 mM imidazole. The sample was sonicated, and
cell debris removed by centrifugation. TbPDF1 recombinant
proteins were puriﬁed by affinity chromatography on Ni-NTA
Agarose columns (Qiagen). The columns were washed with
an excess of buffer A containing 20 mM imidazole, and the
His-tagged proteins were eluted with a linear 20–110 mM
imidazole gradient in buffer A. The eluted proteins were dialy-
sed against 20 mM Tris (pH 8.0), 1 mM 2-mercaptoethanol
containing 55% glycerol and stored in aliquots at -30°C.
Purity was assessed to be 70% (TbPDF1), 95% (TbPDF1/
31–260), 10% (TbPDF1/1–209) and 60% (TbPDF1/31–209).
Biochemistry
Peptide deformylase (PDF) activity assays were carried out
in 50 mM HEPES (pH 7.0) at 37°C for 90 min as described
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(Meinnel and Blanquet, 1995). Proteolytic digestion with dif-
ferent concentrations of trypsin (Sigma) of the indicated PDF
variants (Fig. 2) was performed in 0.1 M Tris-HCl (pH 7.7)
containing 1 mM 2-mercaptoethanol. Samples were incu-
bated at 37°C for 15 min, and the reaction was stopped by
the addition of chicken egg-white ovomucoid 2/1 (w/w) with
respect to trypsin. Finally, the reaction products were analy-
sed by 12% SDS-PAGE. To measure zinc content by atomic
absorption spectroscopy, protein samples were dialysed
overnight against a buffer containing 20 mM Tris-HCl
(pH 7.5) containing 0.1 M KCl. Atomic absorbencies were
measured at 213.9 nm in the peak height mode during 5 s
after 0.1 ml injections using a Varian AA220 spectrophotom-
eter equipped with an air-acetylene burner (Serero et al.,
2003). Zinc concentrations in serial dilutions of the enzyme
samples were calculated by comparison with standard solu-
tions of known concentrations.
Production of transgenic T. brucei cell lines
As a tag to localize TbPDF1 and TbPDF2, a 10-amino-acid
epitope of the major structural protein of the yeast Ty1 virus-
like particle was used which is recognized by the monoclonal
antibody BB2 (Bastin et al., 1996). The sequences corre-
sponding to the C-terminal Ty1-tagged proteins were cloned
into a derivative of the plasmid pLew-100, which allows tet-
racycline inducible expression of the tagged proteins (Wirtz
et al., 1999). RNAi of TbPDF1 and TbPDF2 was performed
using stem-loop constructs containing the phleomycin-
resistance gene as described (Bochud-Allemann and
Schneider, 2002). As inserts we used a 715 bp fragment
(nucleotides 65–779) of the TbPDF1 gene and a 644 bp
fragment of the TbPDF2 gene (nucleotides 2–645). To obtain
the double-RNAi cell lines analysed in Fig. 4B, we replaced
the phleomycine-resistance gene of the construct used to
ablate TbPDF2 with the puromycine-resistance gene, and
used the resulting plasmid to transfect the previously char-
acterized single knock-down for TbPDF1. Transfection of
T. brucei, selection with antibiotics, cloning and induction with
tetracycline were conducted as described (McCulloch et al.,
2004). All transgenic cell lines used in this study are based on
T. brucei strain 29–13, which was grown in SDM-79 (Brun
and Schönenberger, 1979) supplemented with 15% FCS,
50 mg ml-1 hygromycin and 15 mg ml-1 G-418. Growth of RNAi
cells was also analysed in SDM-80, a modiﬁed SDM-79 that
lacks glucose and which is supplemented with 10% of dialy-
sed FCS as described (Lamour et al., 2005).
In organello ATP production assays
ATP production assays were performed as described
(Schneider et al., 2007). In total, 107 cell equivalents of the
digitonin-extracted cells from the TbPDF1 RNAi cell line and
the TbPDF2 RNAi cell line were used for each assay. Induc-
tion times for the TbPDF1 and TbPDF2 RNAi cell lines used
for the experiments shown in Fig. 5 were 160 and 100 h
respectively. However, for the TbPDF2 RNAi cell lines, the
same results were obtained for longer induction times. To
induce ATP production, 5 mM of the indicated substrates
(succinate, glycerol-3 phosphate, a-ketoglutarate or
pyruvate/succinate) and 67 mM ofADP was added. After incu-
bation at 27°C for 30 min, the reaction was processed and
the ATP concentration determined as described. Inhibitors
were preincubated with mitochondria for 10 min on ice and
used at the following ﬁnal concentrations: atractyloside
(33.3 mg ml-1) and antimycin (2.7 mM). ATP production was
then induced by the addition of substrate and ADP.
Miscellaneous
RNA for Northern analysis was isolated by the acid guani-
dinium method (Chomczyinski and Sacchi, 1987). The
probes used were random hexamer a-32P dCTP-labelled
double-stranded DNA fragments corresponding to nucle-
otides 65–779 of the TbPDF1 gene and to nucleotides 2–645
of the TbPDF2 gene respectively. Immunoﬂuorescence was
performed as described (Schneider et al., 1987).
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